卡培他滨(Xeloda;1例老年乳腺癌肝骨转移患者的临床研究

D. Rossi, P. Alessandroni, V. Catalano, P. Giordani, A. Baldelli, S. Fedeli, A. Fedeli, V. Casadei, G. Catalano
{"title":"卡培他滨(Xeloda;1例老年乳腺癌肝骨转移患者的临床研究","authors":"D. Rossi, P. Alessandroni, V. Catalano, P. Giordani, A. Baldelli, S. Fedeli, A. Fedeli, V. Casadei, G. Catalano","doi":"10.5580/1752","DOIUrl":null,"url":null,"abstract":"This case report concerns an elderly patient with liver and bone metastases of breast cancer successfully treated for two-years with capecitabine as first line chemotherapy without any side effect.","PeriodicalId":22534,"journal":{"name":"The Internet Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2005-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer\",\"authors\":\"D. Rossi, P. Alessandroni, V. Catalano, P. Giordani, A. Baldelli, S. Fedeli, A. Fedeli, V. Casadei, G. Catalano\",\"doi\":\"10.5580/1752\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This case report concerns an elderly patient with liver and bone metastases of breast cancer successfully treated for two-years with capecitabine as first line chemotherapy without any side effect.\",\"PeriodicalId\":22534,\"journal\":{\"name\":\"The Internet Journal of Oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Internet Journal of Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5580/1752\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Internet Journal of Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5580/1752","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

本病例报告涉及一位老年乳腺癌肝骨转移患者,卡培他滨作为一线化疗成功治疗2年,无任何副作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Durable Response To Capecitabine (Xeloda; Roche) In An Elderly Patient With Liver And Bone Metastases Of Breast Cancer
This case report concerns an elderly patient with liver and bone metastases of breast cancer successfully treated for two-years with capecitabine as first line chemotherapy without any side effect.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信